Zydus Wellness Limited has informed the Exchange about change in Management

Management Changes View source PDF Explain this filing

ZYDUSWELL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.1%Reaction day

₹404.40

prior close

₹405.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.6%+3.8% vs market

Packaged Foods peers, median of 32sector-0.1%+2.3% vs sector

On the reaction day the stock moved 3.8 pts more than Nifty Smallcap 250 and 2.3 pts more than its Packaged Foods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.7

15m

-0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.1-1.6+3.8-0.1+2.3

Next day

+1.4-0.7+2.1-0.5+1.9

-2.0-1.0-1.0-1.7-0.3

-3.0-2.2-0.8-2.2-0.8

-4.5-2.3-2.2-0.9-3.6

-3.9-3.5-0.3-2.7-1.2

-4.5-3.1-1.5-2.0-2.5

15d

-2.0-0.5-1.5-2.6+0.6

+10.5-2.4+12.9-1.7+12.2

+13.8-1.6+15.4-4.1+17.9

+18.4+1.7+16.8-3.0+21.4

UpDownMarket · Nifty Smallcap 250Sector · Packaged Foods peers, median of 32Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Two senior managers at Zydus Wellness have resigned effective end of business on July 31, 2025. Dr. Siva M. Sivaramakrishnan, Head of R&D, is leaving to pursue a better career opportunity after roughly a year with the company. Mr. Manoj Kothari, Vice President of Global Demand & Supply Organization, is also leaving for better growth prospects. The CEO Mr. Tarun Arora and the promoter-led board remain unchanged. The resignations are being disclosed under SEBI's Regulation 30 as changes in Senior Management.

Likely market impact

The exits affect R&D leadership and supply chain functions, which are critical for a consumer wellness company. Short-term transition risk exists, though Dr. Sivaramakrishnan's note mentions he has ensured launch readiness for upcoming products. Shareholders should watch for any slowdown in new product launches or supply disruptions over the next quarter.